DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Ifosfamide

Ifosfamide

  • VIP - Ifosfamide, Cisplatin and Etoposide

    VIP - Ifosfamide, Cisplatin and Etoposide

  • Hodgkin Lymphoma Treatment Regimens

    Hodgkin Lymphoma Treatment Regimens

  • Docetaxel, Ifosfamide and Cisplatin (DIP) in Squamous Cell Carcinoma of the Head and Neck

    Docetaxel, Ifosfamide and Cisplatin (DIP) in Squamous Cell Carcinoma of the Head and Neck

  • Arsenic Trioxide Is Highly Cytotoxic to Small Cell Lung Carcinoma Cells

    Arsenic Trioxide Is Highly Cytotoxic to Small Cell Lung Carcinoma Cells

  • Combination Chemotherapy with Estramustine Phosphate, Ifosfamide and Cisplatin for Hormone-Refractory Prostate Cancer

    Combination Chemotherapy with Estramustine Phosphate, Ifosfamide and Cisplatin for Hormone-Refractory Prostate Cancer

  • Prospective Randomized Clinical Trial Comparing High-Dose Ifosfamide + GM-CSF Vs High-Dose Cyclophosphamide + GM-CSF for Blood Progenitor Cell Mobilization

    Prospective Randomized Clinical Trial Comparing High-Dose Ifosfamide + GM-CSF Vs High-Dose Cyclophosphamide + GM-CSF for Blood Progenitor Cell Mobilization

  • Systemic Therapy for Advanced Soft Tissue Sarcoma

    Systemic Therapy for Advanced Soft Tissue Sarcoma

  • Inp Doxorubicin Etoposide Ifosfamide Vincristine Videver1

    Inp Doxorubicin Etoposide Ifosfamide Vincristine Videver1

  • Treatment and Prophylaxis of Ifosfamide-Induced Encephalopathy with Intravenous Methylene Blue

    Treatment and Prophylaxis of Ifosfamide-Induced Encephalopathy with Intravenous Methylene Blue

  • Ifosfamide and Etoposide-Based Chemotherapy As Salvage and Mobilizing Regimens for Poor Prognosis Lymphoma

    Ifosfamide and Etoposide-Based Chemotherapy As Salvage and Mobilizing Regimens for Poor Prognosis Lymphoma

  • The Cost Burden of Blood Cancer Care a Longitudinal Analysis of Commercially Insured Patients Diagnosed with Blood Cancer

    The Cost Burden of Blood Cancer Care a Longitudinal Analysis of Commercially Insured Patients Diagnosed with Blood Cancer

  • Cancer Drug Costs for a Month of Treatment at Initial Food

    Cancer Drug Costs for a Month of Treatment at Initial Food

  • Salvage Chemotherapy for Hormone-Refractory Prostate Cancer: Association of Adriamycin and Ifosfamide

    Salvage Chemotherapy for Hormone-Refractory Prostate Cancer: Association of Adriamycin and Ifosfamide

  • Acronyms for Oncology Regimens

    Acronyms for Oncology Regimens

  • BC Cancer Protocol Summary for 3-Day Doxorubicin – Ifosfamide - Mesna for Use in Patients with Advanced Soft Tissue Sarcoma

    BC Cancer Protocol Summary for 3-Day Doxorubicin – Ifosfamide - Mesna for Use in Patients with Advanced Soft Tissue Sarcoma

  • No Additional Benefit of Adding Ifosfamide to Docetaxel in Castration-Resistant Metastatic Prostate Cancer

    No Additional Benefit of Adding Ifosfamide to Docetaxel in Castration-Resistant Metastatic Prostate Cancer

  • Inp Doxorubicinifosfamidever1

    Inp Doxorubicinifosfamidever1

  • High-Dose Ifosfamide and Etoposide with Filgrastim for Stem Cell Mobilization in Patients with Advanced Ovarian Cancer

    High-Dose Ifosfamide and Etoposide with Filgrastim for Stem Cell Mobilization in Patients with Advanced Ovarian Cancer

Top View
  • Chemotherapy Extravasation Management
  • BC Cancer Protocol Summary for Doxorubicin – Ifosfamide - Mesna for Use in Patients with Advanced Soft Tissue Sarcoma
  • Ifosfamide Richard J. Cardosi, MD, FACOG
  • Evolution of Nitrogen-Based Alkylating Anticancer Agents
  • Chapter 11. Chemotherapy and Kidney Injury
  • Ifosfamide in Combination with Paclitaxel Or Doxorubicin
  • High Dose Ifosfamide in Relapsed and Unresectable High-Grade Osteosarcoma Patients: a Retrospective Series
  • Proposal for the Inclusion of Mesna (Sodium 2-Mercaptoethane Sulfonate)
  • Emetogenic Potential of Antineoplastic Agents
  • Computationally Predicting Clinical Drug Combination Efficacy With
  • BC Cancer Protocol Summary for 3-Day Etoposide and Ifosfamide- Mesna for Patients with Advanced Soft Tissue Or Bony Sarcomas
  • IFEX (Ifosfamide for Injection, USP)
  • North Carolina Division of Health Benefits Physician Administered Drug Program Catalog
  • Triplet Chemotherapy with Cisplatin, Ifosfamide and 5-Fluorouracil in Advanced Anal Cancer. a Population Based Retrospective An
  • Principles of Antineoplastic Therapy
  • GUVEIP Protocol
  • BC Cancer Protocol Summary for Etoposide, Ifosfamide-Mesna (SAIME) Alternating with Vincristine, Doxorubicin and Cyclophosphamid
  • Systemic High-Dose Methotrexate Plus Ifosfamide Is Highly Effective For


© 2024 Docslib.org    Feedback